Crystal structure and transient dimerization for the FKBP12 protein from the pathogenic fungus Candida auris

Qamar Bashir1, Zhong Li1, Hongmin Li1

  • 1Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, NY, 12201, USA.

Insights

Candida auris is a growing threat due to drug resistance. Researchers studied its FKBP12 protein structure and interactions to help design new antifungal drugs that reduce virulence and side effects.

Area of Science:

  • Medical Mycology
  • Structural Biology
  • Drug Discovery

Background:

  • Emergence of multidrug-resistant Candida auris infections poses a significant global health threat.
  • The FK506-binding protein FKBP12 and calcineurin pathway are known virulence factors in fungal pathogens.
  • Modifications to FK506 show potential for reducing fungal virulence and immunosuppression.

Purpose of the Study:

  • To determine the crystal structure of Candida auris FKBP12.
  • To characterize the homodimerization interactions of FKBP12 from Candida auris and Candida glabrata.

Main Methods:

  • X-ray crystallography was used to determine the crystal structure of Candida auris FKBP12.
  • Solution Nuclear Magnetic Resonance (NMR) spectroscopy was employed to study homodimerization interactions.

Main Results:

  • The crystal structure of Candida auris FKBP12 was determined.
  • Homodimerization interactions of FKBP12 from Candida auris and Candida glabrata were characterized in solution.

Conclusions:

  • Structural and interaction data for Candida auris FKBP12 can aid structure-based drug design.
  • Understanding FKBP12 interactions may lead to novel antifungal strategies targeting Candida species.
  • This research contributes to developing new treatments for resistant fungal infections.